- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Merck & Co. Inc. (MRK)
Index:
- Change Today: $2.18
- 52 Week High: $122.66
- 52 Week Low: $73.47
- Currency: US Dollars
- Shares Issued: 2,527.64m
- Volume: 622
- Market Cap: $308,195m
- RiskGrade: 92
- Beta: 0.01
Latest ShareCast News
Merck beats on fourth quarter revenue but disappoints on outlook
By Josh White
Date: Tuesday 03 Feb 2026
(Sharecast News) - Merck & Co reported better-than-expected fourth-quarter results on Tuesday, driven by continued strength in its oncology franchise and animal health division, but shares slipped after the drugmaker issued a 2026 outlook that fell short of market expectations as it braced for patent expiries and generic competition.
Merck ShareCast News
Merck Newspaper Links
Merck Tips & Analysis
Merck News Wires
No recent information was found.
Merck Market Data
| Currency | US Dollars |
| Share Price | $ 121.93 |
| Change Today | $ 2.18 |
| % Change | 1.82 % |
| 52 Week High | $122.66 |
| 52 Week Low | $73.47 |
| Volume | 622 |
| Shares Issued | 2,527.64m |
| Market Cap | $308,195m |
| Beta | 0.01 |
| RiskGrade | 92 |
What The Brokers Say
| Strong Buy | 8 |
| Buy | 10 |
| Neutral | 10 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 28 |
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
You are here: research
Digital Look Ltd,
10 Lower Thames St,
London EC3R 6EN
10 Lower Thames St,
London EC3R 6EN